Novel hematopoietic stem cell specification signals from the neural crest
Novel hematopoietic stem cell specification signals from the neural crest
批准号:
10174919
负责人:
WILSON Kendrick Clements
金额:
$40.39万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-02 至 2024-05-31
关键词:
AdultAnimalsAortaBloodBone MarrowBone Marrow TransplantationCalcitoninCellsClinicalDataDefectDescending aortaDevelopmentDiseaseDorsalEmbryoEmbryonic InductionEndotheliumEngraftmentFishesFluorescenceFoundationsGenerationsGenesGoalsHematological DiseaseHematopoieticHematopoietic Stem Cell SpecificationHematopoietic SystemHematopoietic stem cellsImmuneIn VitroKnowledgeLabelLeadLifeMalignant - descriptorMammalsModelingMorphogenesisMusNeural CrestNeural Crest CellNeuropeptidesNon-MalignantOpticsPatternPluripotent Stem CellsProcessResearchSignal InductionSignal TransductionSpecific qualifier valueTestingTherapeuticTimeTissuesTransgenesTransgenic AnimalsVertebratesWorkZebrafishadrenomedullincell typegene therapyhematopoietic stem cell differentiationhematopoietic stem cell formationhemogenic endotheliumin vivoinduced pluripotent stem cellinterestloss of functionmutantneurotransmissionnovelprogenitorprogramsreceptorself-renewalstem cell therapy
中文摘要
项目总结
英文摘要
Project Summary
Hematopoietic stem cells (HSCs) are the foundation of the adult hematopoietic system. These self-renewing
progenitors that reside in the adult bone marrow generate all mature blood lineages through life. Clinically,
HSCs are the therapeutic component of bone marrow transplants, used in the treatment of both malignant and
non-malignant blood disorders. Inconsistent availability of donors, limitations in graft material, and the possible
use of in vitro derived HSCs as a platform for gene therapy and gene editing approaches to treatment of
disease has heightened interest in directed differentiation of HSCs from pluripotent precursors, such as
induced pluripotent stem (iPS) cells. But despite decades of research, generation of true HSCs with high
efficiency engraftment and full multilineage potential remains impossible, suggesting that key specification
signals remain to be determined. An obvious means of instructing HSC specification in vitro is by attempting to
recapitulate the normal embryonic inductive processes. Across vertebrate phyla, HSCs are specified from
developing arterial endothelium, most notably in the primitive descending aorta of mammalian embryos, or its
cognate, the dorsal aorta in anamniotic vertebrates such as zebrafish. Significant progress towards generation
of the immediate precursor to HSCs, the “hemogenic endothelium”, has been made in recent years, but the full
set of inductive signals that work directly on this endothelium to initiate the definitive hematopoietic program
has not been determined. Specification signals likely come from neighboring cells that form an inductive
specification “niche.” As nothing is known about the origin or composition of such cells, we set out to define
cell types that might contribute to the specification niche. Hematopoietic programming is highly conserved from
mammals to zebrafish, and in vivo observation of tissue specification and hematopoietic development is highly
accessible in fish, due to their rapid development, optical transparency at the times when HSCs are specified,
and the availability of diverse transgenic animals in which tissue and cell types are labeled by fluorescence
transgenes. In preliminary studies with zebrafish, we have determined that neural-crest-derived cells are the
first known cell type contributing to the HSC specification niche. Our results show that neural crest cells
physically contact hemogenic endothelium shortly before the HSC program initiates. Multiple separate
perturbations causing defects in neural crest specification or morphogenesis lead to a loss of HSCs,
demonstrating that proper neural crest patterning is required for HSC specification. These data establish neural
crest cells as a key component of the inductive HSC specification niche, indicating that signals they present
are critical to instruct initiation of the hematopoietic program. Here we propose to identify the unknown HSC
specification signals presented by neural crest, and establish the conservation of neural crest contribution to
the HSC specification niche in mammals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Wnt Signaling in Hematopoietic Stem Cell Specification and Leukemia
-
批准号:8111654
-
项目类别:
-
资助金额:$13.89万
-
财政年份:2011
-
负责人:WILSON Kendrick Clements
-
依托单位:
Wnt Signaling in Hematopoietic Stem Cell Specification and Leukemia
-
批准号:8529684
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2011
-
负责人:WILSON Kendrick Clements
-
依托单位:
Wnt Signaling in Hematopoietic Stem Cell Specification and Leukemia
-
批准号:8535188
-
项目类别:
-
资助金额:$23.12万
-
财政年份:2011
-
负责人:WILSON Kendrick Clements
-
依托单位:
Wnt Signaling in Hematopoietic Stem Cell Specification and Leukemia
-
批准号:8669046
-
项目类别:
-
资助金额:$23.17万
-
财政年份:2011
-
负责人:WILSON Kendrick Clements
-
依托单位:
海外基金